Cardinal Health, Inc.
Location
Ohio
Founded
1979-02-28
Website
Risk Signals
3281 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Medical, Dental, and Hospital Equipment and Supplies, Drugs, Drug Proprietaries, and Druggists' Sundries, Management Services), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about Cardinal Health, Inc.
Live alerts from global media, monitored by Business Radar
2025-05-01 (finimize.com)
Cardinal Health Ups Forecast Again On Thriving Specialty Medicines -
Strong demand for high-margin specialty drugs prompts Cardinal Health to raise its adjusted profit outlook for 2025 for the fourth time.
Read more
2025-04-16 (whatech.com)
Face Mask Market Report Explores Development, Industry Trends, Demand and Growth Analysis and Forecasts 2032
The Face Mask Market is projected to grow from USD 5.2 billion in 2024 to approximately USD 9.4 billion by 2032, driven by ongoing health awareness and pollution concerns. This represents a compound annual growth rate (CAGR) of around 7.4% from 2024 to 2032.
Read more
2024-09-25 (via.news)
Artificial Intelligence Forecasts the Next Session’s Prices Changes For Everbridge Corporation, America Movil Corporation, Sabre Corporation
VIANEWS – The Innrs AI algorithm today suggests a high likelihood of discovering tomorrow’s approximate price of Everbridge EVBG and America Movil AMX.
Read more
2021-11-10 (khn.org)
Shipping Backlog Blamed For Driving Rising Costs In Medical Supply Industry
The CEO of Cardinal Health blamed congestion in shipping ports and high commodities prices for causing a rise in the cost of making and distributing medical supplies. Separately, a report says priv…
Read more
2016-10-28 (foxbusiness.com)
The Unusual Argument Explaining Why Drug Wholesalers Are Getting Slammed Today
McKesson Corporation said that a lack of drug price increases will hurt its business going forward.
Read more